Preview

Journal of Anatomy and Histopathology

Advanced search

CDX2 Protein as a Surrogate Marker of Gastric Mucosal Atrophy

https://doi.org/10.18499/2225-7357-2021-10-3-60-67

Abstract

The aim of the study is to develop an approach to assess the severity of the gastric mucosa (GM) atrophy based on the immunohistochemical (IHC) technique to improve diagnostic quality of the stage of chronic gastritis (CG) and to implement predictive assessment of risk factors of gastric cancer development.
Material and methods. The study included 155 cases of CG selected in accordance with Operational Link for Gastritis Assessment (OLGA)-system (2 samples of antral gastric mucosa (GM), 1 sample of angular GM and 2 samples of corpus GM). All biopsy samples were examined using histological and IHC (CDX2) techniques. An expression semi-quantitative index was developed to characterize CDX2. The results obtained were statistically processed using the Mann-Whitney and Kruskal-Wallis tests, the Spearman correlation coefficient, and the construction of logistic regression models.
Results. It was found that the value of the CDX2 index assessed within the GM biopsy samples positively correlates with the gradation of atrophy (r=0.665 (p<0.001)). A positive correlation remains between the CDX2sum index, calculated by summing the CDX2 index values at each of the GM points, and the stage of chronic gastritis according to the OLGA classification (r=0.70 (p<0.01)). When assessing the contribution of changes at each point of biopsy sampling and retrospective correlation of the CDX2 index at two points of the GM and the stage of chronic gastritis, the greatest correlation was found for points 3 (stomach angle) and 5 (greater curvature of the gastric body), at three points – for points 1 (greater curvature antrum), 3 and 5 (r=0.592 (p<0.01)). Logistic regression models were built to predict the stage of chronic gastritis based on the CDX2 index in the specified combinations of points. The following model was chosen as the optimal one: to take biopsies at three points (1, 3, 5) and assess their CDX2 index, with sensitivity equal 80.4%, specificity equal 82.8% and diagnostic accuracy equal 83.9%.
Conclusion. The CDX2 semi-quantitative index can be used to evaluate GM atrophy. The performed regression analysis demonstrates its predictive role. The constructed regression model based on the CDX2 semi-quantitative index calculation at two/three points of GM allows increasing predictive value of biopsy investigations and accuracy of stratified assessment of the gastric adenocarcinoma risk development in patients with CG.

About the Authors

M. N. Parygina
Omsk State Medical University
Russian Federation

Mariya Parygina

ul. Lenina, 12, Omsk, 644099



S. I. Mozgovoi
Omsk State Medical University
Russian Federation

Omsk



A. G. Shimanskaya
Omsk State Medical University
Russian Federation

Omsk



A. V. Kononov
Omsk State Medical University
Russian Federation

Omsk



References

1. Aruin LI, Kononov AV, Mozgovoi SI. Atroficheskii gastrit: problemy obosnovaniya morfologicheskogo diagnoza (materialy k peresmotru mezhdunarodnykh klassifikatsii – OLGA i ATROPHY CLUB). Aktual'nye voprosy patologicheskoi anatomii: materialy III s"ezda Rossiiskogo obshchestva patologoanatomov. 2009; 5–8 (in Russian).

2. Kononov AV, Mozgovoy SI, Shimanskaya AG, Markelova MV, Osintseva IL, et al. The russian revision of chronic gastritis classification: reproducibility of the pathomorphologic picture. Archives of pathology. 2011;4(73):52–6 (in Russian).

3. Shimanskaya AG. Morphological methods and expert approach for verification of gastric mucosa atrophy in biopsy diagnosis of atrophic gastritis. Young scientist. 2012;4:496–505 (in Russian).

4. Correa P, Piazuelo MB. The gastric precancerous cascade. J Dig Dis. 2012;13(1):2–9. doi:10.1111/j.1751-2980.2011.00550.x

5. Dixon MF, Genta RM, Yardley JH, Correa P. Classification and grading of gastritis. The updated Sydney System. International Workshop on the Histopathology of Gastritis, Houston 1994. Am J Surg Pathol. 1996 Oct;20(10):1161–81. doi: 10.1097/00000478-199610000-00001

6. Kononov AV. Patent RU № 188389; 2019 (in Russian).

7. Mattiuzzi C, Lippi G. Current Cancer Epidemiology. J Epidemiol Glob Health. 2019;9(4):217–22. doi:10.2991/jegh.k.191008.001

8. Mozgovoy SI. Patent RU № 2711621; 2020 (in Russian).

9. Rugge M, Correa P, Di Mario F, El-Omar E, Fiocca R, Geboes K, et al. OLGA staging for gastritis: A tutorial. Digestive and Liver Disease. 2008 Aug;40(8):650–8. doi: 10.1016/j.dld.2008.02.030

10. Zhou Y, Li HY, Zhang JJ, Chen XY, Ge ZZ, Li XB. Operative link on gastritis assessment stage is an appropriate predictor of early gastric cancer. World J Gastroenterol. 2016;22(13):3670–8. doi:10.3748/wjg.v22.i13.3670


Review

For citations:


Parygina M.N., Mozgovoi S.I., Shimanskaya A.G., Kononov A.V. CDX2 Protein as a Surrogate Marker of Gastric Mucosal Atrophy. Journal of Anatomy and Histopathology. 2021;10(3):60-67. (In Russ.) https://doi.org/10.18499/2225-7357-2021-10-3-60-67

Views: 463


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 2225-7357 (Print)